{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:01:34Z","timestamp":1761919294119,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.pharma.2009.11.003","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T00:54:54Z","timestamp":1263516894000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Quels facteurs associ\u00e9s \u00e0 la survenue d\u2019un \u00e9v\u00e9nement iatrog\u00e8ne h\u00e9morragique chez les patients sous antivitamines\u00a0K\u00a0?"],"prefix":"10.1016","volume":"68","author":[{"given":"A.H.","family":"Al Hajje","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Calop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Bosson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Calop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Allenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.pharma.2009.11.003_bib1","first-page":"297","article-title":"H\u00e9morragies intracr\u00e2niennes associ\u00e9es \u00e0 un traitement anticoagulant oral\u00a0: analyse de 38\u00a0observations","volume":"57","author":"Gras-Champel","year":"2002","journal-title":"Therapie"},{"key":"10.1016\/j.pharma.2009.11.003_bib2","first-page":"347","article-title":"Mobilisation pour les antivitamines\u00a0K","volume":"12","author":"Drouet","year":"2000","journal-title":"Sang Thrombose Vaisseaux"},{"issue":"Suppl 3","key":"10.1016\/j.pharma.2009.11.003_bib3","first-page":"202","article-title":"Complications h\u00e9morragiques des antivitaminiques K\u00a0: \u00e0 propos de 75\u00a0patients hospitalis\u00e9","volume":"24","author":"Constans","year":"1999","journal-title":"J Mal Vasc"},{"key":"10.1016\/j.pharma.2009.11.003_bib4","unstructured":"Modalit\u00e9s de prescription des anticoagulants et connaissances des patients sur leur traitement. \u00c9tude 2003. http:\/\/afssaps.sante.fr\/htm\/10\/avk\/etude5.htm, version de 8\u00a0janvier 2004."},{"key":"10.1016\/j.pharma.2009.11.003_bib5","unstructured":"http:\/\/www.sante.gouv.fr\/htm\/publication\/colloque_eneis\/produits_sante.pdf."},{"key":"10.1016\/j.pharma.2009.11.003_bib6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archinte.164.14.1557","article-title":"The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major haemorrhage","volume":"164","author":"Koo","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib7","unstructured":"http:\/\/adiph.org\/sfpc\/Dictionnaire_SFPC_EM.pdf."},{"key":"10.1016\/j.pharma.2009.11.003_bib8","unstructured":"Vous et votre traitement anticoagulant oral par anti-vitamine\u00a0K (AVK). http:\/\/agmed.sante.gouv.fr\/htm\/5\/5710c.htm, mise \u00e0 jour janvier 2004."},{"issue":"Suppl 546","key":"10.1016\/j.pharma.2009.11.003_bib9","first-page":"1563","article-title":"Les antivitamines\u00a0K entre h\u00e9morragie et thrombose","volume":"15","author":"Dequin","year":"2001","journal-title":"Rev Prat"},{"key":"10.1016\/j.pharma.2009.11.003_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(89)80689-8","article-title":"Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy","volume":"87","author":"Landefeld","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0002-9343(99)00267-3","article-title":"Major bleeding after hospitalization for deep-venous thrombosis","volume":"107","author":"White","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib12","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.161.17.2125","article-title":"Oral anticoagulant and hemorrhagic complications in an elderly population with atrial fibrillation","volume":"161","author":"Copland","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.pharma.2009.11.003_bib14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4065\/70.8.725","article-title":"Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester Minnsota","volume":"70","author":"Gitter","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pharma.2009.11.003_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2796.1991.tb00358.x","article-title":"Bleeding complications to oral anticoagulation therapy: Multivariate analysis of 1010\u00a0treatment years in 551\u00a0outpatients","volume":"229","author":"Launbjerg","year":"1991","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archinte.1996.00440040081009","article-title":"The stroke prevention in atrial fibrillation investigators. Bleeding during anti-thrombotic therapy in patients with atrial fibrillation","volume":"156","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1055\/s-0037-1616088","article-title":"Characteristics of anticoagulant therapy and comorbidity related to over anticoagulation","volume":"86","author":"Penning-van Beest","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pharma.2009.11.003_bib18","doi-asserted-by":"crossref","first-page":"108S","DOI":"10.1378\/chest.119.1_suppl.108S","article-title":"Hemorrhagic complications of anticoagulant treatment","volume":"119","author":"Levine","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.pharma.2009.11.003_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-118-7-199304010-00005","article-title":"Risk factors for complications of chronic anticoagulation: A multicenter study. Warfarin optimized outpatient follow-up study group","volume":"118","author":"Fihn","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib21","doi-asserted-by":"crossref","first-page":"970","DOI":"10.7326\/0003-4819-124-11-199606010-00004","article-title":"The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National consortium of anticoagulation clinics","volume":"124","author":"Fihn","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib22","first-page":"972","article-title":"Surdosage en antivitamine\u00a0K dans une population de patients hospitalis\u00e9s \u00e2g\u00e9s de plus de 70\u00a0ans\u00a0: enqu\u00eate prospective sur un an","volume":"32","author":"Siguret","year":"2003","journal-title":"Presse Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib23","first-page":"659","article-title":"Antivitamines K\u00a0: prescription, surveillance","volume":"123","author":"Denis","year":"2001","journal-title":"Fiches de transparences"},{"key":"10.1016\/j.pharma.2009.11.003_bib24","first-page":"269","article-title":"\u00c9ducation th\u00e9rapeutique du patient\u00a0: r\u00f4les du pharmacien","volume":"367","author":"Jacquemet","year":"2000","journal-title":"Bull Ordre Med"},{"year":"2008","series-title":"Pharmacie clinique et th\u00e9rapeutique","author":"Calop","key":"10.1016\/j.pharma.2009.11.003_bib25"},{"key":"10.1016\/j.pharma.2009.11.003_bib26","first-page":"425","article-title":"Anticoagulation orale\u00a0: s pratiques","volume":"17","author":"Niederer","year":"2001","journal-title":"Rev Med Suisse"},{"issue":"Suppl 3","key":"10.1016\/j.pharma.2009.11.003_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0398-0499(04)96737-6","article-title":"Impact d\u2019un programme d\u2019\u00e9ducation th\u00e9rapeutique sur les attitudes de pr\u00e9vention vis-\u00e0-vis du risque iatrog\u00e8ne\u00a0: \u00e9tude pilote contr\u00f4l\u00e9e visant les patients sous anticoagulants oraux pour maladie thromboembolique veineuse","volume":"29","author":"L\u00e9ger","year":"2004","journal-title":"J Mal Vasc"},{"key":"10.1016\/j.pharma.2009.11.003_bib28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s11606-008-0690-1","article-title":"Educ\u2019AVK\u00a0: Reduction of oral anticoagulant-related adverse events after patient education: A prospective multicenter open randomized study","volume":"23","author":"Pernod","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ancard.2005.10.003","article-title":"The anticoagulation clinic: That cannot be ignored","volume":"55","author":"Boccalon","year":"2006","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.pharma.2009.11.003_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(98)04147-6","article-title":"Multicentrer randomised study of computerised anticoagulant dosage. European concerted action on anticoagulant","volume":"352","author":"Poller","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pharma.2009.11.003_bib31","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/archinte.158.15.1641","article-title":"Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs","volume":"158","author":"Chiquette","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharma.2009.11.003_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0248-8663(02)00019-X","article-title":"Les centres de suivi et de conseils des traitements anticoagulants\u00a0: un outil pour diminuer le nombre de complications h\u00e9morragiques associ\u00e9es aux anti-vitamine\u00a0K","volume":"24","author":"Levesque","year":"2003","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.pharma.2009.11.003_bib33","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1378\/chest.127.5.1515","article-title":"Effect of centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy","volume":"127","author":"Witt","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pharma.2009.11.003_bib34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.revmed.2009.02.004","article-title":"Exp\u00e9rience d\u2019un centre de suivi et de conseil des traitements anticoagulants oraux en m\u00e9decine de ville\u00a0: r\u00e9sultats \u00e0 cinq ans","volume":"30","author":"Benhamou","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.pharma.2009.11.003_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)68139-7","article-title":"Self-monitoring of oral anticoagulation: A systematic review and meta-analysis","volume":"367","author":"Heneghan","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pharma.2009.11.003_bib36","unstructured":"http:\/\/unaformec-ra.over-blog.com\/article-24155903.html."},{"key":"10.1016\/j.pharma.2009.11.003_bib37","unstructured":"Deccache A. Quelles pratiques et comp\u00e9tences en \u00e9ducation\u00a0: recommandations de l\u2019OMS. La sant\u00e9 de l\u2019homme\u00a0;1999:341."},{"year":"1989","series-title":"Information et \u00e9ducation du patient","author":"Deccache","key":"10.1016\/j.pharma.2009.11.003_bib38"},{"key":"10.1016\/j.pharma.2009.11.003_bib39","unstructured":"http:\/\/www.escardio.org\/about\/press\/press-releases\/esc09-barcelona\/Pages\/HotLine1-Connolly-RE-LY-study.aspx."}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450909001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450909001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:28:01Z","timestamp":1757719681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450909001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0003450909001722"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2009.11.003","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quels facteurs associ\u00e9s \u00e0 la survenue d\u2019un \u00e9v\u00e9nement iatrog\u00e8ne h\u00e9morragique chez les patients sous antivitamines\u00a0K\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2009.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}